206 related articles for article (PubMed ID: 4617716)
1. Minimum inhibitory and bactericidal dosages of rifampici against Mycobacterium leprae in the mouse foot pad: relationship to serum rifampicin concentrations.
Holmes IB
Int J Lepr Other Mycobact Dis; 1974; 42(3):289-96. PubMed ID: 4617716
[No Abstract] [Full Text] [Related]
2. Activity of ascorbic acid in inhibiting the multiplication of M. leprae in the mouse foot pad.
Hastings RC; Richard V; Christy SA; Morales MJ
Int J Lepr Other Mycobact Dis; 1976; 44(4):427-30. PubMed ID: 798727
[TBL] [Abstract][Full Text] [Related]
3. The effect of rifampicin and dapsone on experimental Mycobacterium leprae infections: minimum inhibitory concentrations and bactericidal action.
Holmes IB; Hilson GR
J Med Microbiol; 1972 May; 5(2):251-61. PubMed ID: 4555734
[No Abstract] [Full Text] [Related]
4. In vivo susceptibility of Mycobacterium leprae to ofloxacin either singly or in combination with rifampicin and rifabutin. Anti-leprosy activity of ofloxacin and ansamycins in mice.
Dhople AM; Ibanez MA
Arzneimittelforschung; 1994 Apr; 44(4):563-5. PubMed ID: 8011013
[TBL] [Abstract][Full Text] [Related]
5. Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice.
Ji B; Perani EG; Petinon C; Grosset JH
Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):556-61. PubMed ID: 1338596
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo effects of N-methyl-3,5-dichloro-benzylamine hydrochloride on Mycobacterium leprae.
Dhople AM; Strong LC; Meindl W; Schoenenberger H; Gardner GD
Arzneimittelforschung; 1991 Mar; 41(3):253-6. PubMed ID: 1867663
[TBL] [Abstract][Full Text] [Related]
7. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
Walker LL; Van Landingham RM; Shinnick TM
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
[TBL] [Abstract][Full Text] [Related]
8. Rifampin in drug-incorporated diet: effect of duration and temperature of storage. Relevance to drug-susceptibility testing in mice inoculated with M. leprae.
Abraham B; Cariappa A; Chacko CJ
Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):68-75. PubMed ID: 2030317
[TBL] [Abstract][Full Text] [Related]
9. Mouse foot pad growth of M. leprae in relation to bacteriological index.
Bhatia VN; Balakrishnan S; Venkataramaniah HN; Harikrishnan S
Lepr India; 1983 Apr; 55(2):247-51. PubMed ID: 6355651
[TBL] [Abstract][Full Text] [Related]
10. Minimal inhibitory dosage of rifampicin in intermittent treatment of Mycobacterium leprae infection in mice.
Pattyn SR; Saerens EJ
Zentralbl Bakteriol Orig A; 1975 May; 231(4):503-7. PubMed ID: 1101580
[TBL] [Abstract][Full Text] [Related]
11. [Dapsone inhibition of the bactericidal action of rifampicin on Mycobacterium leprae in mice].
Millan J; Moulia-Pelat JP
Med Trop (Mars); 1989; 49(4):337-41. PubMed ID: 2695734
[TBL] [Abstract][Full Text] [Related]
12. Mouse foot-pad studies with M. leprae--effect of desoxy fructo serotonin (DFS) and related compounds.
Balakrishnan S; Mester L; Venkataramaniah HN; Bhatia VN
Indian J Lepr; 1985; 57(2):323-8. PubMed ID: 3908578
[TBL] [Abstract][Full Text] [Related]
13. Recent bacteriologic, immunologic and pathologic studies on experimental human leprosy in the mouse foot pad.
Rees RJ
Int J Lepr; 1965; 33(3):Suppl:646-57. PubMed ID: 5322707
[No Abstract] [Full Text] [Related]
14. Activities of pefloxacin and ciprofloxacin against Mycobacterium leprae in the mouse.
Guelpa-Lauras CC; Perani EG; Giroir AM; Grosset JH
Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):70-7. PubMed ID: 3549940
[TBL] [Abstract][Full Text] [Related]
15. Immunological potential of a cultivable mycobacterial strain M. habana against leprosy bacillus in mouse foot pad.
Singh NB; Srivastava ; Gupta HP; Sreevatsa ; Desikan KV
Indian J Lepr; 1985; 57(2):278-81. PubMed ID: 3908575
[TBL] [Abstract][Full Text] [Related]
16. The mouse foot-pad technique for cultivation of Mycobacterium leprae.
Levy L; Ji B
Lepr Rev; 2006 Mar; 77(1):5-24. PubMed ID: 16715686
[TBL] [Abstract][Full Text] [Related]
17. In vivo antileprosy activity of the newly synthesized benzoxazinorifamycin, KRM-1648.
Tomioka H; Saito H
Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):255-8. PubMed ID: 8371034
[TBL] [Abstract][Full Text] [Related]
18. Considerations of the application of the foot pad technic in leprosy research.
Shepard CC
Int J Lepr; 1965; 33(3):Suppl:657-61. PubMed ID: 5322708
[No Abstract] [Full Text] [Related]
19. Activity of ofloxacin against Mycobacterium leprae in the mouse.
Grosset JH; Guelpa-Lauras CC; Perani EG; Beoletto C
Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):259-64. PubMed ID: 3045223
[TBL] [Abstract][Full Text] [Related]
20. An in vitro culture method for screening new drugs against Mycobacterium leprae.
Dhople AM; Ortega I
Indian J Lepr; 1990; 62(1):66-75. PubMed ID: 2193063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
